Navigation Links
MedCath Announces Acquisition of Ownership in Arizona Cath Lab
Date:4/2/2008

CHARLOTTE, N.C., April 2, 2008 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced today that MedCath Partners, LLC has acquired a 27.4 percent interest in a joint venture known as Southwest Arizona Heart and Vascular Center, LLC. The joint venture provides cardiac catheterization lab services to Yuma Regional Medical Center (the "Hospital") in Yuma, Arizona under a Management and Service Agreement with the Hospital.

The joint venture will be owned by MedCath and Heart, Lung and Vascular Center of Yuma, Inc., a physician owned entity. The facility is located on the campus of Yuma Regional Medical Center, about 180 miles southwest of Phoenix.

As part of the agreement, MedCath Partners, LLC will assume management of the joint venture. MedCath will also work with the physicians and hospital to add additional capacity to the facility as well as work to add additional services to the outlying community.

"We are very pleased to announce this new partnership with Heart, Lung and Vascular Center of Yuma, Inc.," said Ed French, MedCath's President and Chief Executive Officer. "The top-quality medical staff and hospital and MedCath have a common belief that our collective strengths will add to an already- successful venture. This venture is the fourth added since last summer, confirming our belief that MedCath Partners is a key element in our strategic growth plan for MedCath."

"We are excited about the launch of this partnership with MedCath," said Dr. Khidir Osman with Heart, Lung and Vascular Center of Yuma, Inc. "MedCath clearly shares our commitment to deliver superior cardiovascular services to the Hospital and this region and bring our care to a growing number of patients."

MedCath acquired its 27.4 percent interest for $8.5 million and anticipates that the joint venture will add approximately $0.05 in diluted earnings per share annually.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates ten hospitals with a total of 663 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties. Although management believes that these forward- looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.

These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Form 10-K filed with the Securities and Exchange Commission on December 14, 2007. A copy of this registration statement, including exhibits, is available on the internet site of the Securities and Exchange Commission at http://www.sec.gov .


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
2. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
3. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
4. MedCath Announces Venture With Two New Jersey Hospitals
5. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
6. MedCath Corporation Reports First Quarter Earnings
7. MedCath Corporation to Hold Conference Call on First Quarter Results
8. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
9. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
10. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
11. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... ... Sun City is the place to be on March 3rd to learn about the latest ... hosting this educational seminar from 5:30 p.m. – 7:00 p.m. Exciting advancements will be presented ... addition, prizes will be given away and light refreshments will be served. , As ...
(Date:2/13/2016)... ... ... Many individuals looking to lead a healthy lifestyle have decreased carbohydrate consumption and increased ... has delved into this niche allowing those giving up their beloved pasta a chance ... grams of protein and only 7 grams of carbohydrates per 50 gram serving--a ratio ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly released ... visualization technology should be used to ensure patient safety when placing an IV ... Standards mandate the use of vein visualization technology in patients with difficult venous ...
(Date:2/13/2016)... ... February 13, 2016 , ... In the early or ... groom themselves to perfection, go out of their way to be romantic, and may ... take a look at any online dating profile. , A recent study from ...
(Date:2/12/2016)... San Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... of love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. ... in fact a love story, the love of a Buddhist teacher for teaching and ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016 - ... in Personalized Medicine and Cancer Therapy. - European ... Diagnostic Testing Markets. - Key Diagnostic Testing Markets. ... Molecular Diagnostics in Genetic Testing. - Molecular Diagnostics ... - Over-the-Counter Diagnostic Products World Markets. - ...
(Date:2/11/2016)... FRANCISCO , Feb. 11, 2016  Kindred Biosciences, ... on saving and improving the lives of pets, today ... Section of the New Animal Drug Application (NADA) for ... pivotal field study (KB0120) of Zimeta for the control ... the Company. --> --> ...
(Date:2/11/2016)... -- NOIT™ Research LLC, a private, leading-edge autism research group, ... assist needy families in obtaining one of its special ... 10, 2016 and March 31, 2016, the company will ... is an auditory stimulus that plays a key role ... Beth Shier , NOIT Research director. "The ...
Breaking Medicine Technology: